## |Contents|Page| |---|---| |Report ofthe Trustees|| |Independent
Examiner's
Report|18| |Statement ofFinancial Activities|19| |Statement ofFinancial Position|20| |Notes tothe Financial Statements|21| |Detailed Statement of Financial Activities|28| ## |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).| |3.2 Commonwealth
Partnerships
forAntimicrobial
Stewardship
(CwPAMS| |---| |In September 2018the CPA, in partnership
with the Tropical
Health
and Education
Trust| |(THET), received funding from the UK Department
ofHealth and Social Care's Fleming Fund| |to develop
the
Commonwealth
Partnerships
for Antimicrobial
Stewardship
(CwPAMS)| |programme.
This scheme isdelivered
via THET's very successful Health Partnerships
Scheme| |(HPS). The
CPA
provides
key technical
support
to the
partnerships
on
antimicrobial| |stewardship
(AMS) and clinical pharmacy.
The programme
was originally
due to finish
in| |May 2020 but has been granted
an extension toJune 2021due tothe COVID19 pandemic.| |The aims ofthe programme
were to strengthen
workforce in:| |~
Antimicrobial
prescribing
(including
informed
by clinical data and using decision tools)| |~
Antimicrobial
stewardship
practices (including
surveillance
ofuse)| |~
Infection prevention
and control.| |Prior to COVID19, CwPAMS involved
volunteer
NHS pharmacists,
specialist nurses, medics| |and
health
psychologists
travelling
to participating
Commonwealth
nations to work
in| |partnership
with
local health
workers,
sharing
expertise
and jointly tackling the growing| |challenge
of AMR. Originally,
12 partnerships
were awarded
grants
across 4 countries:| |Ghana, Tanzania,
Uganda
and Zambia,
with the intention
of sharing
skills and knowledge,| |and toco-create innovation
in AMS. Participating
teams from the NHS undertook 1-2 annual| |placements
of 1-2 weeks at hospital
sites
in Commonwealth
countries.
Between
visits,| |teams kept in touch through
online mentoring
arrangements.
This programme
ofwork has| |the aim of supporting
countries
to deliver
on their
national
AMR action
plans through| |facilitating better stewardship
ofantimicrobials
and infection prevention
control processes.| |By Q3, 5096 of objectives were achieved,
and the original
programme
achieved
all of its| |planned objectives.| |Intermediate
outcomes include:| |OUTCOME 1:LMIC healthcare
institutions
and workforce improved
practice related to AMS| |1500LMIC healthcare
workers trained,
including 253 pharmacists
in AMS —up-skilling| |8 role creation across projects| |Monitoring of behavioural
change has been conducted
(full results pending)| |Improved
prescribing
practice and collaboration
between
prescribers
&lab —expected| |in all by end ofprogramme| |OUTCOME 2:AMS strategies,
guidelines
and tools in place and being used| |Antimicrobial
Stewardship
checklist 8 behavioural
tools| |15new or revised documents
relating to AMS and AntibioticAbx
prescribing
practices| |(zero before)| |CwPAMS
app
(including
national
treatment
guidelines,
WHO
guidelines,
IPC 8| |surveillance)| |Medicines &Therapeutics
Committees| |AMS champions| |Global Point Prevalence
Surveys (GPPS) in 10hospitals
(previously
only 1)e.g. Korle Bu| |2000+ bed PPS (pooled national
results
being used to guide national
strategy,
as well| |as local intervention).|